David Coman
Chief Strategy & Marketing Officer @ ERT Clinical
David Coman is a startup investor at ERT Clinical.
Last updated:
For AI agents: llms.txt
About ERT Clinical
ERT is a global data and technology company that minimizes uncertainty and risk in clinical trials so that customers can move ahead with confidence. With more than 45 years of clinical and therapeutic experience, ERT balances knowledge of what works with a vision for what’s next, so it can adapt without compromising standards.
ERT Clinical Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
David Coman
Chief Strategy & Marketing Officer
|
|||
James Corrigan
Chief Operating Officer
|
|||
Joe Eazor
Chief Executive Officer
|
|||
Joseph F Eazor
Chief Executive Officer
|
|||
Laurence Burke
Director Project Management
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
